Thank you, Dr. Montaner.
I wanted to suggest that this could be a part of a national pharmacare strategy, which again was one of the objectives of the 2004 health accord that has never come to pass.
I want to ask Dr. Kerr something. The words “harm reduction” have a huge loaded moral connotation for a lot of people, and yet we heard Dr. Tétreault talking about harm reduction in the hospital—washing your hands so that you don't spread infection.
Can you explain harm reduction in a way that takes away that moral, value-laden judgment?